Syzygium polycephalum
Syzygium polycephalum · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Syzygium polycephalum is a botanical species that has garnered significant interest in the field of pharmacological research. Recent scientific investigations have focused on its unique chemical composition, specifically identifying the presence of 3,4,3'-Tri-O-methylellagic acid. This particular compound is being studied for its potential therapeutic properties and biological activities. Researchers are particularly interested in evaluating how these phytochemicals might influence various cellular pathways related to cancer. Consequently, this plant represents a promising subject in the ongoing search for novel anti-tumor agents.
- Synonyms
- Eugenia Polycephala · Jambosa Polycephala · 1 more
- Common names
- Not available
- Family
- Myrtaceae
- Distribution
- Asia-Temperate
- Plant Parts
- Not available
Classification
Common Names
Syzygium polycephalum is a fascinating plant that is recognized by several different regional names. Depending on the local area, it is frequently referred to by its common name, Gowok. In other communities, the species is widely known as Kaliasem. It is also quite commonly identified as Kupa by those familiar with its growth patterns. These diverse names highlight the plant's widespread cultural and botanical significance across various regions.
Sources: Catalogue of Life (COL)
Synonyms
Syzygium polycephalum is a botanical species that has been identified under several different scientific names throughout history. Due to various taxonomic classifications, it is widely recognized by the synonym Eugenia polycephala. Researchers have also documented its connection to the name Jambosa cauliflora in older literature. Furthermore, the plant is frequently associated with the synonym Jambosa polycephala in botanical records. Understanding these overlapping identities is essential for accurate plant identification and scientific study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Syzygium polycephalum belongs to the vast kingdom Plantae, representing a diverse branch of the natural world. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Myrtales, which helps define its specific evolutionary lineage. As a member of the family Myrtaceae, it shares structural characteristics with many other well-known flowering plants. Finally, this species is identified by its placement within the genus Syzygium.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Myrtaceae |
| Genus | Syzygium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Syzygium polycephalum is a plant species widely distributed throughout the tropical regions of Asia. It is primarily found within the Malesia botanical region, spanning a diverse array of island ecosystems. Specifically, its presence extends across the lush landscapes of Borneo and Sumatera. The species can also be identified in the unique environments of Jawa and Sulawesi. Furthermore, its natural range encompasses the various islands of the Lesser Sunda archipelago.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Syzygium polycephalum is a distinctive tree species characterized by its sturdy, self-supporting growth form. This botanical specimen typically reaches a substantial size, standing as a prominent feature in its natural habitat. Depending on environmental conditions, its height can vary significantly, often measuring at least 8 meters. Most individuals tend to grow even larger, with minimum heights reaching 12 meters. Ultimately, this impressive tree can reach a maximum height of 20 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Syzygium polycephalum serves as a valuable source of the natural compound 3,4,3'-tri-O-methylellagic acid (T-EA), which acts as a candidate drug for cancer treatment. Research indicates that this isolated compound demonstrates significant inhibition activity against specific cancer cell lines. Specifically, the T-EA derived from the plant shows promise in treating breast cancer by targeting the T47D cell line. Furthermore, the compound exhibits effectiveness against cervical cancer through its impact on the HeLa cell line. These findings highlight the potential of Syzygium polycephalum derivatives to function as medicinal agents against both cervical and breast cancers.